Mandate

Vinge has advised InnKap 4 Partners L.P., in connection with an investment in PBM Sweden AB

December 11, 2009

Vinge has advised InnKap 4 Partners L.P., in connection with an investment in PBM Sweden AB. PBM Sweden AB and InnovationsKapital have entered into a long-term co-operation in which the fund, InnKap 4 Partners L.P., will invest approximately SEK 20 million in return for equity, shares and options.

PBM Sweden AB conducts scientifically-based vocational programmes and training focused on rehabilitation, management and organisational development. The part of the operation directed toward behavioural therapy focuses on improving the quality of life for people who suffer primarily from work and stress-related problems as well as increasing productivity through improved management and healthier employees. The company’s customer base includes county councils, insurance companies and private limited companies.

The Vinge team included responsible partner Malin Ohlin-Åkermark and associate Nina Farrahi.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026